Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.

Journal Article

Fuerstenau, Moritz, Fink, Anna-Maria, Herling, Carmen, Maurer, Christian, Kutsch, Nadine, De La Serna, Javier, Coscia, Marta, Crespo, Marta, Bosch, Francesc ORCID: 0000-0001-9241-2886, Noesslinger, Thomas, Ghia, Paolo, Kater, Arnon P., Ritgen, Matthias, Schilhabel, Anke, Stilgenbauer, Stephan, Tausch, Eugen, Fischer, Kirsten, Hallek, Michael J. and Eichhorst, Barbara (2018). B-cell acute lymphoblastic leukemia (BALL) in CLL patients treated with lenalidomide. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Bosch, Francesc ORCID: 0000-0001-9241-2886 and Hallek, Michael (2018). Venetoclax after idelalisib: relevant progress for CLL. Blood, 131 (15). S. 1632 - 1636. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fink, Anna Maria, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Aldaoud, Ali, Hebart, Holger, Jentsch-Ullrich, Kathleen, Doerfel, Steffen, Fischer, Kirsten, Wendtner, Clemens-Martin, Noesslinger, Thomas, Ghia, Paolo ORCID: 0000-0003-3750-7342, Bosch, Francesc ORCID: 0000-0001-9241-2886, Kater, Arnon P., Dohner, Hartmut, Kneba, Michael, Kreuzer, Karl-Anton, Tausch, Eugen, Stilgenbauer, Stephan, Ritgen, Matthias, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2017). Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Lancet Haematol., 4 (10). S. E475 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Fink, Anna Maria, Bahlo, Jasmin, Sandra, Robrecht, Al-Sawaf, Othman, Aldaoud, Ali, Hebart, Holger, Jentsch-Ulrich, Kathleen, Doerfel, Steffen, Fischer, Kirsten, Wendtner, Clemens Martin, Noesslinger, Thomas, Ghia, Paolo, Bosch, Francesc ORCID: 0000-0001-9241-2886, Kater, Arnon P., Kreuzer, Karl-Anton, Dohner, Hartmut, Kneba, Michael, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2016). Lenalidomide Maintenance after Front Line Therapy Substantially Prolongs Progression Free Survival in High Risk CLL: Interim Results of a Phase 3 Study (CLL M1 study of the German CLL Study Group). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stadler, Nicolas ORCID: 0000-0001-8212-7459, Shang, Aijing, Bosch, Francesc ORCID: 0000-0001-9241-2886, Briggs, Andrew ORCID: 0000-0002-0777-1997, Goede, Valentin, Berthier, Aurelien, Renaudin, Corinne and Leblond, Veronique (2016). A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia. Adv. Ther., 33 (10). S. 1814 - 1831. NEW YORK: SPRINGER. ISSN 1865-8652

Goede, Valentin, Fischer, Kirsten, Bosch, Francesc ORCID: 0000-0001-9241-2886, Follows, George, Frederiksen, Henrik ORCID: 0000-0001-8905-0220, Cuneo, Antonio, Ludwig, Heinz, Crompton, Noelle, Maurer, Joerg, Uguen, Marianne, Fingerle-Rowson, Gunter and Hallek, Michael (2015). Updated Survival Analysis from the CLL11 Study: Obinutuzumab Versus Rituximab in Chemoimmunotherapy-Treated Patients with Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rawstron, Andy, Fazi, Claudia, Villamor, Neus, Delgado, Julio ORCID: 0000-0002-5157-4376, Letestu, Remi, Cymbalista, Florence, Palacio, Carlos, Bosch, Francesc ORCID: 0000-0001-9241-2886, De Tute, Ruth M., Liptrot, Stuart, O'Brien, David, Spacek, Martin ORCID: 0000-0001-5250-8218, Dobber, Johan, Kater, Arnon P., Gambell, Peter C., Westerman, David A., Soosapilla, Asha, Mulligan, Stephen P., Lozanski, Gerard, Lin, Ke, Pettitt, Andrew R., Brachtl, Gabi, Egle, Alexander, Williamson, David W., Sanders, Catherine M., Robins, Harlan, Boysen, Justin, Shanafelt, Tait D., Hanson, Curtis A., Jorgensen, Jeffrey L., Wierda, William G., Yuan, Constance, Stetler-Stevenson, Maryalice, Rassenti, Laura, Broome, H. Elizabeth, Kipps, Thomas J., Hauwel, Mathieu, Marinov, Iuri, Craig, Fiona E., Josep, Nomdedeu, Moreno, Carol, Stehlikova, Olga, Doubek, Michael, Pospisilova, Sarka, Kreuzer, Karl-Anton, Hallek, Michael, Hillmen, Peter, Montserrat, Emili and Ghia, Paolo (2014). A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichhorst, Barbara, Bahlo, Jasmin, Fink, Anna Maria, Pfreundschuh, Michael, Hebart, Holger, Maschmeyer, Georg, Jentsch-Ulrich, Kathleen, Doerfel, Steffen, Westermann, Anne, Zey, Aline, Fischer, Kirsten, Wendtner, Clemens-Martin, Noesslinger, Thomas, Ghia, Paolo, Bosch, Francesc ORCID: 0000-0001-9241-2886, Kater, Arnon P., Kreuzer, Karl-Anton, Doehner, Hartmut, Stilgenbauer, Stephan, Boettcher, Sebastian and Hallek, Michael (2014). Good Tolerance of Lenalidomide Maintenance Therapy in Patients with High Risk Profile Chronic Lymphocytic Leukemia (CLL) after Frontline Chemoimmunotherapy: Preliminary Safety Overview of the CLLM1 Trial of the German CLL Study Group (GCLLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Wendtner, Clemens, Hillmen, Peter, Mahadevan, Daruka, Stilgenbauer, Stephan, Uharek, Lutz, Coutre, Steven, Frankfurt, Olga, Bloor, Adrian, Bosch, Francesc ORCID: 0000-0001-9241-2886, Furman, Richard R., Kimby, Eva, Gribben, John G., Gobbi, Marco, Dreisbach, Luke, Hurd, David Duane, Sekeres, Mikkael A., Ferrajoli, Alessandra, Shah, Sheetal, Zhang, Jennie, de Parseval, Laure Moutouh and Chanan-Khan, Asher A. (2010). Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL-001 Study). Blood, 116 (21). S. 591 - 593. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

This list was generated on Mon Jan 24 08:33:42 2022 CET.